Description: From the 1986 Valuation Actuary Symposium, held in Washington DC in October 1986 Discussion of emerging practice and regulations of the NAIC and New York Insurance Department with respect to requirements placed on the methods and assumptions used by the valuation actuary in producing the support for the Actuarial Opinion as to the adequacy of reserves for life insurance companies

Description: Panelists discuss many developments over the year 1991 that impact the valuation actuary. Session 1 of the 1991 Valuation Actuary Symposium.

Description: 2003 Valuation Actuary Symposium, San Diego, CA. This session provided an overview of current statutory valuation issues pertaining to life and annuity products. Topics included: 1. Actuarial opinion and memorandum regulation amendments. 2. Progress on variable products reserving standards. 3. Regulation XXX mortality factors. 4. Adoption of the 2001 CSO. 5. Progress on the C-3 Phase II RBC project. 6. An update on annuity and life nonforfeiture.

Description: 1993 SOA Meeting, Quebec. The new SVL has expanded the scope and responsibilities of the valuation actuary. Topics covered: • Risk of legal liability for actuaries? • Vagueness of actuarial standards related to adequacy testing? • Reliance on other company experts? • Consultants versus company actuary perspectives? • The science versus the art of the process?

Description: This presentation is from session number 2, presented at the 1999 Valuation Actuary Symposium, held September 23-24 in Los Angeles. The panelists discuss current statutory valuation issues pertaining to life and annuity products. They provide updates on the Unified Valuation Law [UVL] Task Force, equity-indexed products [including NAIC actuarial guidelines ZZZ and ZZZZ], NAIC actuarial guidelines XXXIII and XXXIV, variable annuity guaranteed living benefits VAGLB, the NAIC Model Regulation for Group Annuity Separate Accounts, Actuarial Opinion and Memorandum Regulation [AOMR] revisions, and other current topics.

Description: This session at the 1998 Valuation Actuary Symposium looks at a variety of valuation issues including the Unified Valuation System, codification, the actuarial opinion and memorandum, and several annuity and life insurance reserving issues.

Description: This presentation is a panel discussion, session number 2PD, from the 2000 Valuation Actuary Symposium, held September 14-15 in Washington, DC. The panelists provide an overview of current statutory valuation issues pertaining to life and annuity products, to be covered in-depth at subsequent sessions. Topics include: new valuation table for life insurance NAIC Actuarial Guidelines [AG] for variable product guaranteed living benefits and for equity-indexed universal life [ZZZZ] amendments to the Actuarial Opinion and Memorandum Regulation [AOMR] progress on Unified Valuation System [UVS] Model Regulations on Separate Accounts Funding Group Contracts with Guarantees, and on Synthetic Guaranteed Investment Contracts [GICs] regulatory concern over liquidity and Regulation XXX mortality X factors.

Description: This session from the 1993 Valuation Actuary Symposium looks at an overview of developments in 1993 including a regulator's viewpoint of various valuation actuary issues, an update on the valuation actuary and health insurance, current developments in reinsurance that should be considered in the valuation process and a sample actuarial opinion and memorandum.

Description: This presentation is a panel discussion, session number 2PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists introduce major life and annuity statutory and GAAP valuation issues, which are covered in depth at subsequent sessions. There is also a brief update on activities of the International Accounting Standards Board [IASB]. Statutory topics include the draft National Association of Insurance Commissioners [NAIC] Actuarial Guideline MMMM for variable products with guaranteed living benefits, amendments to the Actuarial Opinion and Memorandum Regulation [AOMR], Regulation XXX mortality factors, and codification update, potential changes to the Standard Valuation Law, risk-based capital, and adoption of the 2001 CSO Mortality Table for valuation. GAAP topics include Statement of Financial Reporting Standards [SFAS] 133, 141, and 142, and two draft AICPA Statements of Position [SOP], one on nontraditional, long-duration products and another on internal replacements. Discussion from participants is included.

Description: 1988 Valuation Actuary Symposium. In this session, the presenter offered her opinion that, while time consuming and burdensome, the results obtained from testing associated with Regulation 126 are worthwhile.